Back to Search
Start Over
Involvement of bradykinin B1 and B2 receptors in human PMN elastase release and increase in endothelial cell monolayer permeability.
- Source :
-
Immunopharmacology [Immunopharmacology] 1996 Jun; Vol. 33 (1-3), pp. 325-9. - Publication Year :
- 1996
-
Abstract
- Bradykinin (BK) is a potent inflammatory mediator, which can release other inflammatory mediators by interacting with bradykinin B1 and B2 receptors. The role of kinins in regulating human PMN elastase release was studied. BK induced elastase release 5-fold over basal levels. Elastase release was inhibited by both B1 and B2 receptor antagonists. A specific B1 agonist des-Arg10-KD increased elastase release 4-fold. Since elastase has been implicated in vascular leak, the effect of BK on endothelial cell monolayer (EM) permeability was assessed. BK increased EM leak (I125 flux) across the EM, whereas des-Arg10-KD was inactive. When co-cultured with human umbilical vein endothelial cells, des-Arg10-KD-treated PMNs increased EM leak by 35%. The elastase inhibitor AAVPK blocked des-Arg10-KD-induced leak by 80% suggesting that elastase is responsible for the increase in permeability. It is concluded that BK causes increased leak by inducing PMN elastase release via activation of both B1 and B2 receptors. BK blockade and elastase inhibition may be beneficial in inflammatory diseases such as ARDS which is characterized by increased lung permeability and both kinin and PMN activation are thought to participate.
- Subjects :
- Amino Acid Chloromethyl Ketones pharmacology
Bradykinin pharmacology
Cells, Cultured
Endothelium, Vascular drug effects
Humans
In Vitro Techniques
Kallidin analogs & derivatives
Kallidin pharmacology
Leukocyte Elastase antagonists & inhibitors
Neutrophils drug effects
Neutrophils enzymology
Permeability
Receptor, Bradykinin B1
Receptor, Bradykinin B2
Serine Proteinase Inhibitors pharmacology
Endothelium, Vascular metabolism
Leukocyte Elastase metabolism
Neutrophils metabolism
Receptors, Bradykinin metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0162-3109
- Volume :
- 33
- Issue :
- 1-3
- Database :
- MEDLINE
- Journal :
- Immunopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 8856176
- Full Text :
- https://doi.org/10.1016/0162-3109(96)00055-0